Home › Myxoid Liposarcoma
Myxoid Liposarcoma clinical trials recruiting in the U.S.
5 studies for Myxoid Liposarcoma are recruiting participants at sites across the United States.
Recently updated studies
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06843967First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06644755N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
RecruitingEarly phase 1
Ages 18 to 80 · All sexes · Updated Aug 27, 2026 · NCT07261657NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
RecruitingPhase 1
Ages 16 to 80 · All sexes · Updated Jul 29, 2026 · NCT06083883From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.